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The western piperazine fragment is
derived from a readily available pyrazine
by reduction of the aromatic ring. While
we have had success with both asymmet-
ric catalytic reduction and enzymatic routes
to the required (S)-piperazinecarboxami-
de, the method of choice is a classical
resolution/racemization. Resolution is
achieved by crystallization of the bis(L-
pyroglutamic-acid) salt. The undesired
enantiomer is then racemized with base
and recycled. Selective acylation (BoczO)
at the distal nitrogen yields the piperazine
ready for coupling (Scheme 7).
Simply heating the two key fragments
(piperazine + epoxide) followed by re-
moval of the Boc group from the distal
nitrogen produces the penultimate inter-
mediate in 94% yield. Alkylation with
picolyl chloride and sulfate salt formation
give Indinavir Sulfate, the active ingredi-
ent of CRIXIVAJV® with greater than 99%
enantiomeric and chemical purity (Scheme
8).
The chemistry described here is the work of
an heroic team of scientists whom I have the
honor to represent. I would especially like to
acknowledge the team leaders from Merck's Pro-
cess Research Department: Drs. David Askin,
Thomas R. Verhoeven, and R.P.(Skip) Volante;
they and their colleagues have much to be proud
of.
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Application of Enzymes in
Industrial Organic Synthesis
Abstract. Aminopeptidase- and amidase-based methods for the production of enantio-
merically pure amino acids, intermediates for pharmaceuticals and agrochemicals, are
discussed. Furthermore, enzymatic syntheses of the dipeptide sweetener aspartame and
semisynthetic antibiotics (such as ampicillin, amoxicillin, cephalexin, and cefadroxil)
are highlighted.
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Kinetic Resolutions with Aminopepti-
dases and Amidases
pies include D-phenylglycine and D-(p-
hydroxyphenyl)glycine, used as building
blocks for semisynthetic antibiotics, and
L-phenylalanine, one of the constituents
of the dipeptide sweetener aspartame. Pro-
duction capacities for these types of appli-
cations typically are in the order of thou-
sands of tons per year. Other amino acids,
produced on a somewhat smaller scale, are
utilized in various pharmaceutical and
agrochemical applications. For example,
D-valine is used in the synthesis of the
pyrethroid insecticide tluvalinate.
Whereas the naturally occurring ami-
no acids can often be most conveniently
produced using microbial production meth-
ods (fermentation), synthetic amino acids
or amino acids with the nonnatural D-con-
figuration have to be prepared using chem-
ical or chemo-enzymatic techniques. One
particularly useful approach, discovered
by DSM in 1975, is the use of an amino-
peptidase present in Pseudomonas putida
ATCC 12633 according to Scheme 1.
Pseudomonas putida
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D,L-a-amino-acid amide
a-H-Amino Acids
Amino acids ha ve proven to be a versa-
tile class of intermediates for a wide vari-
ety of enantiomerically pure pharmaceuti-
cals and agrochemicals. Classical exam-
There is an ever increasing demand for
enantiomerically pure compounds used as
building blocks but also as active ingredi-
ents in the pharmaceutical and agrochem-
ical industry. In addition to relying on the
existing chiral pool, production methods
include resolution processes via diastereo-
meric salt formation, asymmetric homo-
geneous catalysis, asymmetric synthesis,
and kinetic resolution processes with en-
zymes. In this paper, we will concentrate
on the use of amidases and aminopepti-
dases in (industrial) synthesis. In addition,
recent results with further transformations
of unsaturated amino acids will be dis-
cussed.
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This enzymatic resolution process -
including synthesis of the starting materi-
als and recycling of the undesired isomer
- has been reviewed on several occasions
[1]. In addition to simple alkyl- and aryl-
substituted amino acids, the method can
be applied for a wide variety of specifical-
ly functionalized amino acids, of which
some recent examples are depicted in the Figure. Some recent examples of specifically functionalized amino acids
Figure.
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Scheme 2
Application of Unusual Amino Acids
in Organic Synthesis
a,a-Disubstituted Amino Acids
Enantiomerically pure a,a-disubstitut-
ed a-amino acids, especially a-methyl-
substituted amino acids, are of increasing
interest for the agrochemical and pharma-
ceutical industry. These compounds and
their derivatives may act as enzyme inhib-
itors and several are antagonists of recep-
tors. Analogous to the enzymatic resolu-
tion of a-H-amino acids, we have devel-
oped procedures based on amidase prepa-
rations from Mycobacterium neoaurum
(ATCC 25795) and Ochrobactrum an-
thropi (NCIMB 40321). A whole range of
sterically highly crowded amino acids can
now be prepared on a large scale accord-
ing to Scheme 2.
Catalyst:
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Scheme 4
In the past decades, we have illustrated
the potential ofthe enzyme-mediated syn-
thesis of enantiomerically pure amino-
acid derivatives in different applications
in the field of pharmaceuticals, agrochem-
icals, novel sweeteners, chiralligands for
homogeneous catalysis, etc.
Recently, we have shown that enantio-
merically pure linear olefinic amino-acid
derivatives can also be selectively con-
verted to highly functionalized 6- and 7-
membered ring amino acids using the ring-
closing olefin metathesis catalyst devel-
oped by Grubbs. The principle of the ap-
proach is depicted in Scheme 3 [2].
and a second equivalent of phenylalanine
methyl ester, as depicted in Scheme 4. The
enzyme is both regioselective - only the
a-carboxy group is involved in peptide
bond formation, the ,B-carboxy group re-
mains unaffected - and stereoselective.
Even if D,L-phenylalanine methyl ester is
used as a substrate, only the N-protected
L,L-dipeptide is formed. This is one of the
rare examples of industrial peptide syn-
thesis under thermodynamic control.
Thermolysin-Catalyzed Synthesis of
the Sweetener Aspartame: Enzymatic
Peptide Synthesis Under Thermody-
namic Control
The dipeptide sweetener aspartame is
produced by Holland Sweetener Compa-
ny (HSC), the joint venture between DSM
and TOSOH, on a more than 2000 tons per
year scale using a thermolysin-catalyzed
peptide bond-forming reaction.
The system is under thermodynamic
control due to the formation of an addition
compound (salt) of N-protected aspartame
N-protected L-Asp D,L-PheOMe X = H: aspartame
Enzymatic Synthesis of Semisynthetic
Antibiotics: Enzymatic Peptide Bond
Formation under Kinetic Control
Traditionally, semisynthetic penicillins
like ampicillin and amoxicillin are pre-
pared from 6-aminopenicillic acid (= 6-
APA)and D-phenylglycine or D-(p-hydro-
xyphenyl)glycine, respectively, using
chemical procedures. Also, semisynthetic
cephalosporines like cephalexin and ce-
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Scheme 5
+ HX
sic property of the enzyme used, is one of
the key success factors for industrial ap-
plication of this enzymatic approach, which
has been developed by Chemferm, the
joint venture between DSM and Gist-Bro-
cades.
It has been shown that both enzymatic
hydrolysis and synthesis of amide bonds
offers attractive commercial opportuni-
ties. Advantages of the enzymatic approach
include both stereoselecti vi ty and regiose-
lectivity of the enzyme preparations used,
in combination with the fact that enzymes
may catalyze the formation of peptide
bonds in aqueous solution. Environmen-
tally benign processes for the production
of semisynthetic antibiotics and related
compounds will be part of the realm of
industrial synthesis soon.
Conclusions
HY+
•
synthesis
Penicillin amidase
hydrolysis //~O
+
fadroxil are derived from D-amino-acid
derivatives and 7-amino-desacetyloxy-
cephalosporanic acid (= 7-ADCA). From
an environmental point of view, it is high-
ly desirable to replace the chemical pro-
cesses by an enzymatic method in which a
D-pheny 19lycine or D-(p-hydroxyphenyl)-
glycine derivative is coupled in water to
the j3-lactam unit under kinetic control.
This approach is depicted in Scheme 5.
Due to the resemblance in physical
properties of both starting materials, prod-
ucts, and side products - all contain both
amino and carboxylic-acid functional-
ities-, in combination with the well-known
instability of the ,B-Iactam nucleus under
aqueous conditions, careful downstream
processing is of utmost importance for
success. Moreover, an optimal ratio be-
tween synthesis and hydrolysis, an intrin-
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Chiral Amino Acids:
A Versatile Tool in the Synthesis
of Pharmaceuticals and Fine
Chemicals
Karlheinz Drauz*
Enantiomerically pure compounds (EPC)
can be made by different methods. The
resolution of racemates using enzymes,
optically active acids or bases forming
diastereomeric salt pairs or chromato-
graphic systems are common methods.
The chiral pool offers a great variety of
natural chiral substances which could be
transformed to advanced derivatives; ami-
no acids and sugars are the most promi-
nent examples. Fermention is using the
metabolism ofli ving cells, producing high-
ly effective dedicated compounds based
on sugar or advanced precursors.
Induction of asymmetry using enzymes
or chiral auxiliaries in ideally catalytic
amounts can provide all types of enantio-
Abstract. Methods of preparing enantiomerically pure amino acids especially focusing
on amino-acylase-based resolution of D,L-acetylamino-acid precursors, synthesis of D-
amino acids using a hydantoinase system, and the cofactor-dependent enzymatic
reductive amination of (X-keto acids to L-amino acids are described. Examples are given
for bulk actives, based on L- and D-amino acids and peptides. L- and D-TIe (= L-/D-2-
amino-3,3-dimethylbutanoic acid) are important molecules for synthesizing drugs and a
great variety of chiral auxiliaries. A new chromatographic separation of bulky- side-chain
amino acids in' a preparative scale is described, giving both enantiomers in > 99% ee.
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